Scott Hutton Biodesix Inc (BDSX) insider trading activity

BDSX Quotes by TradingView

Scott Hutton is President & CEO of BIODESIX INC. Currently has a direct ownership of 509,900 shares of BDSX, which is worth approximately $805,642. The most recent transaction as insider was on May 23, 2024, when has been sold 26,120 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 510K
9.65% 3M change
111.82% 12M change
Total Value Held $805,642

Scott Hutton Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2024
BUY
Exercise of conversion of derivative security
-
26,120 Added 4.87%
509,900 Common Stock
May 09 2024
SELL
Open market or private sale
$5,570 $1.48 p/Share
3,764 Reduced 0.77%
483,780 Common Stock
May 08 2024
BUY
Exercise of conversion of derivative security
-
12,212 Added 2.44%
487,544 Common Stock
Feb 12 2024
SELL
Open market or private sale
$49,315 $1.66 p/Share
29,708 Reduced 6.01%
465,011 Common Stock
Feb 09 2024
SELL
Open market or private sale
$66,589 $1.92 p/Share
34,682 Reduced 6.55%
494,719 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
-
199,973 Added 27.42%
529,401 Common Stock
Nov 10 2023
SELL
Open market or private sale
$2,316 $1.23 p/Share
1,883 Reduced 0.57%
329,428 Common Stock
Nov 09 2023
SELL
Open market or private sale
$2,390 $1.27 p/Share
1,882 Reduced 0.56%
331,311 Common Stock
Nov 08 2023
BUY
Exercise of conversion of derivative security
-
12,212 Added 3.54%
333,193 Common Stock
Aug 10 2023
SELL
Open market or private sale
$8,749 $1.27 p/Share
6,889 Reduced 2.12%
318,013 Common Stock
Aug 09 2023
SELL
Open market or private sale
$9,581 $1.39 p/Share
6,893 Reduced 2.08%
324,902 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
-
44,777 Added 11.89%
331,795 Common Stock
Aug 03 2023
BUY
Grant, award, or other acquisition
$74,999 $1.62 p/Share
46,296 Added 13.89%
287,018 Common Stock
May 10 2023
SELL
Open market or private sale
$6,079 $1.58 p/Share
3,848 Reduced 1.57%
240,722 Common Stock
May 09 2023
SELL
Open market or private sale
$15,596 $1.57 p/Share
9,934 Reduced 3.9%
244,570 Common Stock
May 08 2023
BUY
Exercise of conversion of derivative security
-
44,778 Added 14.96%
254,504 Common Stock
Feb 09 2023
SELL
Open market or private sale
$29,300 $1.8 p/Share
16,278 Reduced 7.54%
199,726 Common Stock
Feb 08 2023
BUY
Exercise of conversion of derivative security
-
44,777 Added 17.17%
216,004 Common Stock
Nov 21 2022
BUY
Grant, award, or other acquisition
$74,999 $1.15 p/Share
65,217 Added 27.58%
171,227 Common Stock
Nov 10 2022
SELL
Open market or private sale
$6,208 $1.02 p/Share
6,087 Reduced 5.43%
106,010 Common Stock
Nov 09 2022
SELL
Open market or private sale
$7,997 $1.04 p/Share
7,690 Reduced 6.42%
112,097 Common Stock
Nov 08 2022
BUY
Exercise of conversion of derivative security
-
44,778 Added 27.21%
119,787 Common Stock
Aug 09 2022
SELL
Open market or private sale
$34,494 $2.53 p/Share
13,634 Reduced 15.38%
75,009 Common Stock
Aug 08 2022
BUY
Exercise of conversion of derivative security
-
44,777 Added 33.56%
88,643 Common Stock
May 10 2022
SELL
Open market or private sale
$24,299 $1.83 p/Share
13,278 Reduced 23.24%
43,866 Common Stock
SH

Scott Hutton

President & CEO
Boulder, CO

Track Institutional and Insider Activities on BDSX

Follow BIODESIX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDSX shares.

Notify only if

Insider Trading

Get notified when an Biodesix Inc insider buys or sells BDSX shares.

Notify only if

News

Receive news related to BIODESIX INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BDSX